Precigen

Precigen

Biotechnology Research

Germantown, Maryland 5,117 followers

Precigen (Nasdaq: PGEN) is a biopharmaceutical company advancing the next generation of gene and cell therapies.

Über uns

Precigen: Advancing Medicine with Precision™ Precigen (Nasdaq: PGEN) is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Our technologies enable us to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated unique therapies toward clinical proof-of-concept and commercialization.

Website
http://www.precigen.com
Industrie
Biotechnology Research
Größe des Unternehmens
201-500 Mitarbeiter
Hauptsitz
Germantown, Maryland
Typ
Öffentliches Unternehmen
Spezialitäten
Gene Therapy and Cell Therapy

Standorte

Employees at Precigen

Aktualisierungen

Ähnliche Seiten

Jobs durchsuchen

Finanzierung

Precigen 12 total rounds

Letzte Runde

Eigenkapital nach dem IPO

US$ 30.0M

Siehe mehr Informationen auf crunchbase